Stock listing
LSE:0JBU Intellia Therapeutics, Inc. Share Price
UK listing (LSE) of Intellia Therapeutics, Inc. · home listing NASDAQ:NTLA
Follow Intellia Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · LSE:0JBU
$11.20 USD -0.41 (-3.5%)
Close on Oct 22, 2026
- Day range
- $11.14 – $11.88 USDOct 22, 2026
- Volume
- 11,374 sharesOct 22, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NTLA · Home | $11.16 USD | -0.49 (-4.2%) | 3,650,098 | $11.41 | $11.97 | $10.98 | $11.65 | Close on Oct 22, 2026 |
| LSE:0JBU | $11.20 USD | -0.412 (-3.5%) | 11,374 | $11.30 | $11.88 | $11.14 | $11.61 | Close on Oct 22, 2026 |
| Frankfurt:38I | €10.10 EUR | +0.06 (+0.6%) | 303 | €10.08 | €10.10 | €10.08 | €10.04 | Close on Oct 22, 2026 |
- Ticker
- LSE:0JBU
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- USD
What changed lately
Latest news release · Oct 13, 2026
Intellia Therapeutics Appoints Jing L. Marantz, M.D., Ph.D., as Chief Medical Officer
Latest earnings call · Aug 6, 2026
Intellia Therapeutics (NASDAQ:NTLA) Q2 2026 Earnings Call
Replay and transcript
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 37 slides
Calls
Replays
Intellia Therapeutics (NASDAQ:NTLA) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 8:00 AM ET
Watch TranscriptIntellia Therapeutics (NASDAQ:NTLA) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 8:00 AM ET
Watch TranscriptIntellia Therapeutics (NASDAQ:NTLA) Q3 2025 Earnings Call
Thu, Nov 06, 2025 · 6:00 PM ET
Watch Transcript
Latest news
Decks
Investor Presentation (August 2026)
Investor deck · 37 slides · August 2026
Technical Presentation (April 2026)
Technical · 32 slides · Apr 27, 2026
Investor Presentation (January 2026)
Investor deck · 37 slides · Jan 9, 2026
American Heart Association Scientific Sessions 2025 (AHA25)
Conference · 19 slides · November 2025
Intellia Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 26 in the last 12 months · 188 in all · newest Oct 13, 2026 · oldest 2019
- Calls
- 18 calls with a replay · 18 with a transcript · latest Aug 6, 2026
- Decks
- 17 decks · latest August 2026
Where Intellia Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NTLA · Home listing | NASDAQ | United States | USD |
| gettex:38I | gettex | Germany | EUR |
| LS Exchange:A2AG6H | LS Exchange | Germany | EUR |
| BOATS:NTLA | BOATS | United States | USD |
| Tradegate:38I | Tradegate | Germany | EUR |
| Lang & Schwarz:A2AG6H | Lang & Schwarz | Germany | EUR |
| Hamburg:38I | Hamburg | Germany | EUR |
| LSE:0JBU · This page | LSE | United Kingdom | USD |
| Frankfurt:38I | Frankfurt | Germany | EUR |
| Stuttgart:38I | Stuttgart | Germany | EUR |
| BX Swiss:38I | BX Swiss | Switzerland | CHF |
| Dusseldorf:38I | Dusseldorf | Germany | EUR |
| Munich:38I | Munich | Germany | EUR |
| Hanover:38I | Hanover | Germany | EUR |
| Xetra:38I | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Intellia Therapeutics, Inc.